Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents

Journal of Medicinal Plants Research

Volumn 4, Issue 21, 2010, Pages 2235-2242

  Bustanji, Yasser ^a   Issa, Ala ^a   Mohammad, Mohammad ^a   Hudaib, Mohammad ^a   Tawah, Khalid ^a   Alkhatib, Hatim ^a   Almasri, Ihab ^b   Al Khalidi, Bashar ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

^b AL AZHAR UNIVERSITY   (Palestine)

Author keywords

Diabetes mellitus; Hormone sensitive lipase; Obesity; Pancreatic lipase; Phenolic compounds; Rosemary; Rosmarinic acid; Rosmarinus officinalis

Indexed keywords

CAFFEIC ACID; CHLOROGENIC ACID; GALLIC ACID; HORMONE SENSITIVE LIPASE; METHANOL; PHENOL DERIVATIVE; ROSMARINIC ACID; ROSMARINUS OFFICINALIS EXTRACT; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME SPECIFICITY; EPIDIDYMIS FAT; IC 50; IN VITRO STUDY; JORDAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYTOCHEMISTRY; RAT; STRUCTURE ACTIVITY RELATION;

ROSMARINUS OFFICINALIS;

EID: 78650525429     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Al-Sereiti MR, Abu-Amer KM, Sen P (1999). Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J. Exp. Biol., 37: 124-130.
2. Anthonsen MW, Contreras JA, Fourel D, Holst LS, Karlsson M, Laurell H, Osterlund T, Holm C (1999). Hormone-sensitive lipase - structure, function and regulation. Prog. Obes. Res., 8: 89-96.
3. Bai N, He K, Roller M, Lai C-S, Shao X, Pan M-H, Ho C-T (2010). Flavonoids and Phenolic Compounds from Rosmarinus officinalis. J. Agric. Food Chem., 58: 5363-5367.
4. Bakirel T, Baki{dotless}rel U, Ustuner-Keles O, Gunes-Ulgen S, Yardibi H (2008). In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits J Ethnopharmacol., 116: 64-73.
5. Bassani V, Casadebaig J, Jacob M, Menut C, Lechat I, Lamaty G (1990). Preparation of a low-alcohol extract of Rosmarinus officinalis using a reverse osmosis membrane. Int. J. Pharm., 63: 57-63.
6. Bergman RN, Ader M (2000). Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab., 11: 351-356.
7. Birari RB, Bhutani KK (2007). Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov. Today 12: 879-889.
8. Bustanji Y, Mohammad M, Hudaib M, Tawaha K, Al-Masri IM, AlKhatib HS, Issa A, Alali FQ (2010). Screening of some medicinal plants for their pancreatic lipase inhibitory potential. Jordan J. Pharm. Sci. In Press.
9. Bustanji Y, Moulay A, Hudaib M, Tawaha K, Mohammad M, Issa A, Hamed S, Masri I, Alaali FQ (2010). Hormone sensitive lipase inhibition by selected medicinal plants. J. Med. Plants Res. Accepted.
10. Cicero AFG, Derosa G, Gaddi A (2004). What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks. Acta Diabetol., 41: 91-98.
11. Dearlove RP, Greenspan P, Hartle DK, Swanson RB, Hargrove JL (2008). Inhibition of protein glycation by extracts of culinary herbs and spices. J. Med. Food, 11: 275-281.
12. Dipiro JT, Talbert R, Yee G, Matzke G, Wells B, Posey L (2007). Pharmacotherapy; a pathophysiologic approach. 7th ed.
13. Dubois M, Bailly F, Mbemba G, Mouscadet J-F, Debyser Z, Witvrouw M, Cotelle P (2008). Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro-and dinitrorosmarinic acids as new anti-HIV-1 agents. J. Med. Chem., 51: 2575-2579.
14. El Deeb KS (1993). Investigation of tannin in some Labiatae species. Bull. Fac. Pharm., 31: 237-241.
15. Erenmemisoglu A, Saraymen R, Ustun H (1997). Effect of a Rosmarinus officinalis leave extract on plasma glucose levels in normoglycemic and diabetic mice. Pharmazie 52: 645-646.
16. Erion DM, Shulman GI (2010). Diacylglycerol-mediated insulin resistance. Nat. Med., 16: 400-402.
17. Fabio A, Cermelli C, Fabio G, Nicoletti P, Quaglio P (2007). Screening of the antibacterial effects of a variety of essential oils on microorganisms responsible for respiratory infections. Phytother. Res., 21: 374-377.
18. Fazio G, Vernuccio D, Di Gesaro G, Bacarella D, D'Angelo L, Novo G, Novo S (2010). Obesity: a new pathology to pay attention to in young people. Curr. Pharm. Des., 16: 463-467.
19. Fex M, Mulder H (2008). Lipases in the pancreatic beta -cell: implications for insulin secretion. Biochem. Soc. Trans., 36: 885-890.
20. Furtado RA, Rezende de Araujo FR, Resende FA, Cunha WR, Tavares DC (2010). Protective effect of rosmarinic acid on V79 cells evaluated by the micronucleus and comet assays. J. Appl. Toxicol. 30: 254-259.
21. Gutierrrez R, Alvarado JL, Presno M, Perez-Veyna O, Serrano CJ, Yahuaca P (2010). Oxidative stress modulation by Rosmarinus officinalis in CCl4-induced liver cirrhosis. Phytother. Res., 24: 595-601.
22. Hadafi A, Ismaili Alaoui M, Chaouch A, Benjilali B, Zrira S (1998). Antioxidant activity and phenolic acid content in rosemary (Rosmarinus officinalis L.) and myrtle (Myrtus communis). Riv. Ital. pp. 325-340.
23. Harach T, Aprikian O, Monnard I, Moulin J, Membrez M, Beolor J-C, Raab T, Mace K, Darimont C (2010). Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Planta Med., 76: 566-571.
24. Hasani-Ranjbar S, Larijani B, Abdollahi M (2009). A systematic review of the potential herbal sources of future drugs effective in oxidantrelated diseases. Inflamm Allergy Drug Targets, 8: 2-10.
25. Herrero M, Plaza M, Cifuentes A, Ibanez E (2010). Green processes for the extraction of bioactives from Rosemary: Chemical and functional characterization via ultra-performance liquid chromatography-tandem mass spectrometry and in-vitro assays. J. Chromatogr., 1217: 2512-2520.
26. Holm C, Belfrage P, Oesterlund T, Davis RC, Schotz MC, Langin D (1994). Hormone-sensitive lipase: structure, function, evolution and overproduction in insect cells using the baculovirus expression system. Protein Eng., 7: 537-541.
27. International Diabetes Federation IDF (2010). (PLEASE PROVIDE THE TITLE OF THE WORK)
28. Koga K, Shibata H, Yoshino K, Nomoto K (2006). Effects of 50% ethanol extract from rosemary (Rosmarinus officinalis) on alpha - glucosidase inhibitory activity and the elevation of plasma glucose level in rats, and its active compound. J. Food Sci., 71: S507-S512.
29. Lean MEJ, Campbell P (2004). Orlistat. J. Drug Eval., 2: 179-218.
30. Lee YP, Chung GH, Rhee JS (1993). Purification and characterization of Pseudomonas fluorescens SIK W1 lipase expressed in Escherichia coli. Biochim. Biophys. Acta, Lipids Lipid Metab., 1169: 156-164.
31. Mark EL, Jerry LR, Strauss AW (1989). Cloning and Characterization of Human Pancreatic Lipase cDNA). J. Biol. Chem. 264: 20042-20048.
32. McCue PP, Shetty K (2004). Inhibitory effects of rosmarinic acid extracts on porcine pancreatic amylase in vitro. Asia Pac. J. 13: 101-106.
33. Mohammad MK, Almasri IM, Tawaha K, Issa A, Al-Nadaf A, Hudaib M, AlKhatib HS, Abu-Gharbieh E, Bustanji Y (2010). Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus. Pharm. Biol., In press.
34. Mohammad M, Aiedeh KM, AlKhatib HS, Tawaha K, AlKhalidi B, Al-Masri IM, Hamed S, Bustanji Y (2010b). A comparative enzymatic inhibition assay as a surrogate indicator of pharmaceutical and potency equivalence of two orlistat formulations. Jordan J. Pharm. Sci., 3:69-74.
35. Moon D-O, Kim M-O, Lee J-D, Choi YH, Kim G-Y (2010). Rosmarinic acid sensitizes cell death through suppression of TNF-alpha -induced NF-kB activation and ROS generation in human leukemia U937 cells. Cancer Lett., 288: 183-191.
36. Morimoto C, Sumiyoshi M, Kameda K, Tsujita T, Okuda H (1999). Relationship between hormone-sensitive lipolysis and lipase activity in rat fat cells. J. Biochem., 125: 976-981.
37. Nabekura T, Yamaki T, Hiroi T, Ueno K, Kitagawa S (2010). Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals. Pharmacol. Res., 61: 259-263.
38. Nawroth PP, Rudofsky G, Humpert P (2010). Have we understood diabetes? New tasks for diagnosis and therapy. Exp. Clin. Endocrinol. Diabetes, 118: 1-3.
39. Osterlund T (2001). Structure-function relationships of hormonesensitive lipase. Eur. J. Biochem., 268: 1899-1907.
40. Park SU, Uddin MR, Xu H, Kim YK, Lee SY (2008). Biotechnological applications for rosmarinic acid production in plant. Afr. J. Biotechnol., 7: 4959-4965.
41. Petry S, Ben Ali Y, Chahinian H, Jordan H, Kleine H, Mueller G, Carriere F, Abousalham A (2005). Sensitive assay for hormonesensitive lipase using NBD-labeled monoacylglycerol to detect low activities in rat adipocytes. J. Lipid Res., 46: 603-614.
42. Pfeiffer AFH (2007). Adipose tissue and diabetes therapy: do we hit the target? Horm. Metab. Res., 39: 734-738.
43. Rababah TM, Hettiarachchy NS, Horax R (2004). Total Phenolics and Antioxidant Activities of Fenugreek, Green Tea, Black Tea, Grape Seed, Ginger, Rosemary, Gotu Kola, and Ginkgo Extracts, Vitamin E, and tert-Butylhydroquinone. J. Agric. Food Chem., 52: 5183-5186.
44. Roberts DL, Dive C, Renehan AG (2010). Biological mechanisms linking obesity and cancer risk: new perspective. Annu. Rev. Med., 61: 301-316.
45. Rodbell M (1964). Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem., 239: 375-380.
46. Sanjust E, Mocci G, Zucca P, Rescigno A (2008). Mediterranean shrubs as potential antioxidant sources. Nat. Prod. Res., 22: 689-708.
47. Scarpati ML, Oriente G (1958). Isolation and constitution of rosmarinic acid, from Rosmarinus officinalis. Ricerca Sci., 28: 2329-2333.
48. Shetty K (2007). Rosmarinic acid biosynthesis and mechanism of action. Funct. Foods Biotechnol., 187-207.
49. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HPF, Krempf M (1998). Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet, 352: 167-173.
50. Slanc P, Doljak B, Kreft S, Lunder M, Janes D, Strukelj B (2009). Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition. Phytother. Res., 23: 874-877.
51. Smith GM, Garton AJ, Aitken A, Yeaman SJ (1996). Evidence for a multi-domain structure for hormone-sensitive lipase. FEBS Lett., 396: 90-94.
52. Sotelo-Felix JI, Martinez-Fong D, Muriel De la Torre P (2002). Protective effect of carnosol on CCl4-induced acute liver damage in rats. Eur. J. Gastroenterol. Hepatol., 14: 1001-1006.
53. Taha MO, Dahabiyeh LA, Bustanji Y, Zalloum H, Saleh S (2008). Combining Ligand-Based Pharmacophore Modeling, Quantitative Structure-Activity Relationship Analysis and in Silico Screening for the Discovery of New Potent Hormone Sensitive Lipase Inhibitors. J. Med. Chem., 51: 6478-6494.
54. Takaki I, Bersani-Amado LE, Vendruscolo A, Sartoretto SM, Diniz SP, Bersani-Amado CA, Cuman RKN (2008). Anti-Inflammatory and Antinociceptive Effects of Rosmarinus officinalis L. Essential Oil in Experimental Animal Models. J. Med. Food, 11: 741-746.
55. Vanithadevi B, Anuradha CV (2008). Effect of rosmarinic acid on insulin sensitivity, glyoxalase system and oxidative events in liver of fructose-fed mice. Int. J. Diabetes Metab., 16: 35-44.
56. Verger R (1997). Interfacial activation of lipases: facts and artifacts. Trends Biotechnol., 15: 32-38.
57. Wang H, Provan GJ, Helliwell K (2004). Determination of rosmarinic acid and caffeic acid in aromatic herbs by HPLC. Food Chem., 87: 307-311.
58. Wheatley D (2004). Current role of herbal preparations. Handb. Exp. Pharmacol., 157: 325-351.
59. Yamamoto H, Ono H, Nakagawa K (2005). Lipase inhibitor containing 3,4-dihydroxyphenyl carboxylic acid and/or gallic acid derivatives. (Seres Corporation, Japan). Application: JP, p. 10.